(Q39947427)

15 September 2017

title

YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation (English)

1 reference

15 September 2017

0 references

7

Yasushi Yatabe

1 reference

15 September 2017

Toshihiko Yokoyama

1

1 reference

15 September 2017

Hirotaka Osada

2

1 reference

15 September 2017

Hideki Murakami

3

1 reference

15 September 2017

Yoshio Tatematsu

4

1 reference

15 September 2017

Tetsuo Taniguchi

5

1 reference

15 September 2017

Yutaka Kondo

6

1 reference

15 September 2017

Yoshinori Hasegawa

8

1 reference

15 September 2017

Kaoru Shimokata

9

1 reference

15 September 2017

Yoshitsugu Horio

10

1 reference

15 September 2017

Toyoaki Hida

11

1 reference

15 September 2017

Yoshitaka Sekido

12

1 reference

15 September 2017

language of work or name

English

0 references

publication date

25 August 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

29

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

2139-2146

1 reference

The pathogenesis of mesothelioma

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Advances in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Cellular and molecular parameters of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Transcriptome sequencing of malignant pleural mesothelioma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Implications of P16/CDKN2A deletion in pleural mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Cytogenetic and molecular genetic changes in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Persistent induction of c-fos and c-jun expression by asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Hippo signaling in organ size control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

A mouse model recapitulating molecular features of human mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

A conditional mouse model for malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN200

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN200

1 reference

15 September 2017

1 reference